In summary, we have demonstrated that two glycolysis-promoting, R-point-specific enzymes, PFKFB3 and PFK1, may serve as tool enabling discrimination of CSCs from non-stem cancer cells as well as iPS cells. This evidence concerns the gene PFKFB3 and cancer.